Take Action: SGO Needs Your Help on Two Important Requests
Ask Your Member to Support Legislation to Restore Funding to the Department of Defense CDMRP
On March 14, Congress passed the Fiscal Year (FY) 2025 continuing resolution (CR) to fund the government through September 30. The CR drastically reduces funding for the Department of Defense’s (DoD) Congressionally Directed Medical Research Program (CDMRP) from $1.5 billion to $650 million in 2025 – a 57 percent cut from the FY 2024 enacted levels. Cuts of this magnitude could significantly disrupt research into new therapeutics for diseases, including gynecologic cancers, that impact the health of our nation’s armed services, as well as veterans, military families, and the general public.
SGO needs your help to urge members of Congress to support legislation that would restore full funding to the CDMRP, protecting the Ovarian Cancer Research Program (OCRP) and the Peer Reviewed Cancer Research Programs (PRCRP) which fund crucial gynecologic cancer research in support of service members, veterans, their families, and the public. Please take action now and ask your members of Congress to support bipartisan legislation to restore funding to the CDMRP and protect high-impact research for gynecologic cancers.
Ask Your Member to Sign the Dear Colleague in Support of the Creation of an Endometrial Cancer Research Program
The House is beginning its work on the Fiscal Year (FY) 2026 appropriations bills, including the bill that funds the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP). Representative Bonnie Watson Coleman (D-NJ) is leading a Dear Colleague letter requesting for the establishment of a separate line-item for an endometrial cancer research program with $10 million in initial appropriations.
SGO needs your help to get members of the House of Representatives to sign this Dear Colleague letter in support of this request. Please take action now and ask your representative to sign this letter requesting $10 million for the establishment of a separate line-item for an endometrial cancer research program within the DoD CDMRP.